市場調查報告書
商品編碼
1468184
2024-2032 年按類型、應用、最終用戶和地區分類的人工心肺機市場報告Artificial Heart-Lung Machine Market Report by Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球人工心肺機市場規模達到2.932億美元。
人工心肺機,也稱為心肺旁路 (CPB) 或氧合器泵,用於冠狀動脈繞道、心臟和肺移植以及其他心臟手術。它暫時執行心臟和肺的功能,使外科醫生能夠在運動和無血的手術野中進行手術。這些機器由一個接收血液的腔室組成,然後血液被充氧並循環到身體的所有部位。多年來,這些幫浦在嚴重呼吸衰竭的治療以及心臟手術領域取得了重大進展。
近年來,全球心臟直視手術、心臟移植和肺部手術的數量顯著增加。這主要歸因於各種環境和生活方式的變化,導致心血管疾病和器官衰竭的盛行率增加。除此之外,一些發展中國家的政府正在努力為病患提供更好的醫療設施,這推動了對人工心肺機的需求。此外,市場參與者正在投資研發活動,以使現有的充氧幫浦型號現代化。這些活動促進了模組化心肺機的開發,這些機器本質上具有成本效益、安全且方便用戶使用。除此之外,這些機器還為醫生提供了靈活性,因為它們便於攜帶並且可以使用可充電電池進行操作。製造商也對 CPB 幫浦進行了多項改進,以防止血液過度氧合。
The global artificial heart-lung machine market size reached US$ 293.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 393.7 Million by 2032, exhibiting a growth rate (CAGR) of 3.2% during 2024-2032.
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.
In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial heart-lung machine market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on type, application and end user.
Single Roller Pump
Double Roller Pump
Cardiac Surgeries
Lung Surgeries
Acute Respiratory Failure Treatment
Others
Hospitals and Clinics
Ambulatory Surgical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.